Growth Metrics

Gyre Therapeutics (GYRE) Change in Acquisitions & Divestments (2012 - 2026)

Gyre Therapeutics (GYRE) reported Change in Acquisitions & Divestments of $10.1 million for Q1 2026, down 9.98% year-over-year from $11.2 million in Q1 2025, and up 137.63% on a QoQ basis from $4.2 million in Q4 2025.

Gyre Therapeutics (GYRE) has 13 years of Change in Acquisitions & Divestments data on file, last reported at $10.1 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 9.98% year-over-year to $10.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (up 27.9% YoY) and the FY2025 annual result came in at $15.4 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments improved to $10.1 million in Q1 2026 per GYRE's latest filing, from $4.2 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $11.2 million in Q1 2025 and bottomed at $2.5 million in Q1 2022.
  • The 3-year median for Change in Acquisitions & Divestments is $7.2 million (2025), against an average of $7.0 million.
  • The widest annual swing landed in 2022, when Change in Acquisitions & Divestments slumped 90.92%; it then dropped 9.98% in 2026.
  • Tracing GYRE's Change in Acquisitions & Divestments over 3 years: stood at $2.5 million in 2022, then surged by 69.29% to $4.2 million in 2025, then jumped by 137.63% to $10.1 million in 2026.
  • Per Business Quant, the three latest GYRE Change in Acquisitions & Divestments figures stand at $10.1 million (Q1 2026), $4.2 million (Q4 2025), and $11.2 million (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.07 Mn
Mar 31, 2026 10.07 Mn
Dec 31, 2025 4.24 Mn
Dec 31, 2025 4.24 Mn
Mar 31, 2025 11.19 Mn
Mar 31, 2025 11.19 Mn
Mar 31, 2022 2.50 Mn
Mar 31, 2022 2.50 Mn
Dec 31, 2021 2.87 Mn
Dec 31, 2021 2.87 Mn
Sep 30, 2021 7.53 Mn
Sep 30, 2021 7.53 Mn
Jun 30, 2021 11.05 Mn
Jun 30, 2021 11.05 Mn
Mar 31, 2021 27.58 Mn
Mar 31, 2021 27.58 Mn
Dec 31, 2020 33.48 Mn
Dec 31, 2020 33.48 Mn
Sep 30, 2020 23.59 Mn
Sep 30, 2020 23.59 Mn
Jun 30, 2020 17.04 Mn
Jun 30, 2020 17.04 Mn
Mar 31, 2020 33.46 Mn
Mar 31, 2020 33.46 Mn
Dec 31, 2019 23.47 Mn
Dec 31, 2019 23.47 Mn
Sep 30, 2019 44.96 Mn
Sep 30, 2019 44.96 Mn
Jun 30, 2019 40.73 Mn
Jun 30, 2019 40.73 Mn
Mar 31, 2019 48.27 Mn
Mar 31, 2019 48.27 Mn
Dec 31, 2018 67.63 Mn
Dec 31, 2018 67.63 Mn
Sep 30, 2018 29.64 Mn
Sep 30, 2018 29.64 Mn
Jun 30, 2018 16.76 Mn
Jun 30, 2018 16.76 Mn
Mar 31, 2018 13.94 Mn
Mar 31, 2018 13.94 Mn
Dec 31, 2017 7.50 Mn
Dec 31, 2017 7.50 Mn
Jun 30, 2017 -1,000.00
Jun 30, 2017 -1,000.00
Mar 31, 2017 6.80 Mn
Mar 31, 2017 6.80 Mn
Dec 31, 2016 3.40 Mn
Dec 31, 2016 3.40 Mn
Sep 30, 2016 2.40 Mn
Sep 30, 2016 2.40 Mn
Dec 31, 2015 11.07 Mn
Dec 31, 2015 11.07 Mn
Sep 30, 2015 -28.88 Mn
Sep 30, 2015 -28.88 Mn
Jun 30, 2015 31.35 Mn
Jun 30, 2015 31.35 Mn
Mar 31, 2015 278,000.00
Mar 31, 2015 278,000.00
Dec 31, 2014 14.24 Mn
Dec 31, 2014 14.24 Mn
Sep 30, 2014 10.20 Mn
Sep 30, 2014 10.20 Mn
Jun 30, 2014 7.48 Mn
Jun 30, 2014 7.48 Mn
Mar 31, 2014 9.07 Mn
Mar 31, 2014 9.07 Mn
Dec 31, 2013 14.48 Mn
Dec 31, 2013 14.48 Mn
Sep 30, 2013 18.46 Mn
Sep 30, 2013 18.46 Mn
Jun 30, 2013 20.48 Mn
Jun 30, 2013 20.48 Mn
Mar 31, 2013 16.46 Mn
Mar 31, 2013 16.46 Mn
Dec 31, 2012 30.25 Mn
Dec 31, 2012 30.25 Mn